XTLB
XTL Biopharmaceuticals
XTLB
XTLB
3 hedge funds and large institutions have $556K invested in XTL Biopharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
RhumbLine Advisers
Boston,
Massachusetts
|
$15.8K |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$63.6K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $477K | 198,888 | – | – |
|
|
2
Morgan Stanley
New York
| $63.6K | 26,451 | -6,700 | -20% |
|
|
3
RhumbLine Advisers
Boston,
Massachusetts
| $15.8K | 6,519 | +935 | +17% |
|
|
4
Citadel Advisors
Miami,
Florida
| – | – | -15,435 | Closed |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|